Abstract:Helen Clare Ricketts, 1 Varun Sharma, 1 Femke Steffensen, 2 Elaine Mackay, 3 Gordon Wallace MacDonald, 4 Duncan S Buchan, 5 Michael Lean, 6 Rekha Chaudhuri, 7 Douglas C Cowan 4 1 College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 2 Glasgow Clinical Research Facility, Glasgow Royal Infirmary, Glasgow, UK; 3 Pulmonary Rehabilitation Team, Glasgow Royal Infirmary, Glasgow, UK; 4 Respiratory Department, Glasgow Royal Infirmary, Glasgow, UK; 5 Division of Sports and Exercise, University of the West of Scotland, Glasgow, UK; 6 School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK; 7 Respiratory Department, Gartnavel General Hospital, Glasgow, UK Correspondence: Douglas C Cowan, Email Introduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥ 25 kg/m 2 , and identify response predictors. Methods: A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year. Results: Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5– 38.7) kg/m 2 . At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1– 2.9), 2.2 (1.8– 2.5), and 2.3 (1.9– 2.7), p < 0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5– 3), 1 (0– 2), and 1 (0.5– 2), p < 0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2– 5), 0 (0– 4.7), and 1.5 (0– 4.2), p MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive. Conclusion: Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. Keywords: asthma, difficult-to-treat asthma, obesity, pulmonary rehabilitation Asthma is a heterogeneous condition associated with variable features of cough, wheeze, shortness of breath, and chest tightness, along with variable inflammation of the airways and airway hyper-reactivity. 1 Difficult-to-treat asthma describes asthma with persistent symptoms and/or frequent asthma attacks despite treatment with high-dose inhaled corticosteroids (ICS) plus a long-acting beta 2 agonist (LABA) or leukotriene receptor antagonist (LRTA); or medium-dose ICS plus a LABA or LRTA and an appropriate additional therapy; or continuous or frequent use of oral steroids; and other factors may contribute, eg poor treatment adherence, psychosocial factors, allergy, dysfunctional breathing, and other co-morbidities such as gastro-oesophageal reflux. 2 Obesity is associated with poorer outcomes in asthma, 3–5 and resistance to steroids, 6 the mainstay of asthma treatment. The links between obesity and asthma are complex, multifaceted, and bidirectional, involving changes in chest wall mechanics, airflow limitation, and hyper-responsiveness, as well as increases in inflammation, both systemically and within the airways. 7 Recently there has been a shift towards personalisation of treatment of airways disease by focusing intervention on treatable traits. 8,9 Type 2 inflammation (T2-high asthma) is the treatable trait in asthma with the widest range of treatment options including the biologic treatments targeting IgE, IL-5, and IL-4/13. Obese asthma is a recognised phenotype but with limited treatment options. It is more often associated with T2-low disease, 10–13 and patients may not be eligible for, or respond to, IgE, IL-5, or IL-4/13 targeted therapies; there is a recognition of an obese non-eosinophilic/non-atopic phenotype with late onset, female preponderance, and high symptom expression, 14,15 in particula -Abstract Truncated-

HEALTH-RELATED QUALITY OF LIFE, LUNG FUNCTION AND ASTHMA CONTROL IN OBESE ASTHMATIC INDIAN CHILDREN

Respiratory Health in Overweight and Obese Chinese Children

Effect of obesity on lung function test among adults

Do Obese Inner-City Children with Asthma Have More Symptoms Than Nonobese Children with Asthma?

Translational Study on the Relationships Between Body Mass Index, Levels of Serum Inflammatory Factors and Bronchial Asthma in Children

Increased asthma risk and asthma-related health care complications associated with childhood obesity.

Asthma as a Barrier to Children's Physical Activity: Implications for Body Mass Index and Mental Health

Comparison of Pulmonary Function and Inflammation in Children/Adolescents with New-Onset Asthma with Different Adiposity Statuses

Physical activity and childhood asthma control: Mediation and moderation role of body mass index

Emphasis on Quality of Life in Children and Adolescents With Bronchial Asthma

Comparison of asthma knowledge, management, and psychological burden among parents of asthmatic children from rural and urban neighborhoods in India

Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI.

[Effects of Body Mass Index and Serum Inflammatory Cytokines on Asthma Control in Children with Asthma].

The Association Between Obesity and the Unified Airway in Children

Obesity at the age of 4-5 related to asthma diagnosis in later childhood: A longitudinal study using linked routinely collected data from Wales

A Case-Control Study of Body Mass Index and Asthma in Asian Children.

Cytokines Profile and Lung Function in Children with Obesity and Asthma: A Case Control Study

Asthma phenotype: Clinical, physiological, and biochemical profiles of North Indian patients

Interactive Effects of Obesity and Breastfeeding on Asthma and Asthma-Like Symptoms among Children

[Case-Control Study of the Relationship Between Children's Moderate-Severe Asthma and Development Indicators].

Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma